Anti PSMD14 pAb (ATL-HPA002114)

Catalog No:
ATL-HPA002114-25
$401.00
Application: WB, ICC, IHC 
Clonality: Polyclonal 
Host: Rabbit 
Reactivity: Human, Mouse, Rat 
Protein Description: proteasome (prosome, macropain) 26S subunit, non-ATPase, 14
Gene Name: PSMD14
Alternative Gene Name: pad1, POH1, Rpn11
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000026914: 100%, ENSRNOG00000061129: 100%
Entrez Gene ID: 10213
Uniprot ID: O00487
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Cognate Antibody/Antigen for Anti PSMD14 pAb (ATL-HPA002114)
Antigen PrEST Antigen PSMD14 (ATL-APrEST86205)
Documents & Links for Anti PSMD14 pAb (ATL-HPA002114)
Datasheet Anti PSMD14 pAb (ATL-HPA002114) Datasheet (External Link)
Vendor Page Anti PSMD14 pAb (ATL-HPA002114) at Atlas

Documents & Links for Anti PSMD14 pAb (ATL-HPA002114)
Datasheet Anti PSMD14 pAb (ATL-HPA002114) Datasheet (External Link)
Vendor Page Anti PSMD14 pAb (ATL-HPA002114)

Citations for Anti PSMD14 pAb (ATL-HPA002114) – 6 Found
POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation.
Nat Commun. 2015 Oct 29;6:8704. doi: 10.1038/ncomms9704.  PubMed
POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.
EBioMedicine. 2019 Mar;41:320-332. doi: 10.1016/j.ebiom.2019.01.058. Epub 2019 Feb 7.  PubMed
Tissue profiling of the mammalian central nervous system using human antibody-based proteomics.
Mol Cell Proteomics. 2009 Jul;8(7):1612-22. doi: 10.1074/mcp.M800539-MCP200. Epub 2009 Apr 7.  PubMed
Multiple components of the spliceosome regulate Mcl1 activity in neuroblastoma.
Cell Death Dis. 2014 Feb 20;5(2):e1072. doi: 10.1038/cddis.2014.40.  PubMed
The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
EBioMedicine. 2019 Nov;49:55-71. doi: 10.1016/j.ebiom.2019.10.039. Epub 2019 Nov 1.  PubMed
Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Theranostics. 2021 Jan 1;11(6):2655-2669. doi: 10.7150/thno.48375. eCollection 2021.  PubMed